Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases

Stamatiades, G. A., D’Silva, P., Elahee, M., Viana, G. M., Sideri-Gugger, A., & Majumdar, S. K. (2023). Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases. International Journal of Endocrinology, 2023, 1–7. https://doi.org/10.1155/2023/6615624
Authors:
George A. Stamatiades
Prajna D’Silva
Mehreen Elahee
Gustavo Monteiro Viana
Aristea Sideri
Sachin Majumdar
Affiliated Authors:
Aristea Sideri
Columbia Affiliation:
Subjects:
Management of Diabetes Mellitus and Cardiovascular Risk (OpenAlex Topic)
Role of AMP-Activated Protein Kinase in Cellular Metabolism (OpenAlex Topic)
Pancreatic Islet Dysfunction and Regeneration (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1155/2023/6615624
PMID:
37441367
DOI:
10.1155/2023/6615624
Journal:
International Journal of Endocrinology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: